Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ProDUCT-HF
NCT03892148Phase 4Completed
- Sponsor
- Centre Hospitalier Universitaire de Clermont-Ferrand
- Start
- May 2019
- Primary completion
- Jan 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of furosemide, hydrochlorothiazide in heart failure (HF), sponsored by Centre Hospitalier Universitaire de Clermont-Ferrand. Started May 2019; status: completed.
02
Drugs
furosemidehydrochlorothiazide
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT03892148.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03892148.